Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by GoneBrokeon Jun 25, 2019 11:31am
89 Views
Post# 29860576

Strange that FSD Pharma hasn't mention it's next Harvest

Strange that FSD Pharma hasn't mention it's next Harvest Date ? Or how much yield it expects from it's 20,000 sq.ft. -25,000 sq.ft. of growing space ?
You'd think that now that they have received their amended license , they would be forthcoming with when their harvest is ready , how much yield they expect from the crop and how much they expect from revenues !!
It still has me wondering whether they are growing anything at all ?

Graham B. mentioned that they wrote off any biological yield that they had in storage and if they didn't write it off ; why aren't they mentioning how much is there for potential revenues ?

This company just doesn't disclosed enough details , which is very sketchy !

I'm happy with the amended license but uncertain about any meanful revenues without further buildout and of course like what was posted already today ; they will need to either partner , refinance or dilute in order to buildout.

Receiving a license for oil sales is a must in order the begin revenues through their agreement with World Class Extracts .

Nowhere near out of the woods on this investment yet !
Bullboard Posts